Alvotech (ALVO) Stock Price, Quote, News & History

Key Statistics

Open

$5.28

$5.29

Volume / Avg.

667.87K / 930.88K

Day Range

$5.26 - $5.39

52 Wk Range

2.94 - 9.25

Market Cap

$1.79B

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

3.93%

Days to Cover

4.36

Recent Alvotech SA News

Crude Oil Down 3%; XPeng Shares Fall After Q2 Results

US stocks traded mixed with the Dow Jones index gaining over 150 points. Consumer staples shares jumped while information technology stocks fell. XPeng Inc shares fell 7% due to wider than expected loss and lower revenue outlook.

Avi Kapoor

Napco Security Technologies Posts Upbeat Q4 Results, Joins Alvotech, Rum Group And Other Big Stocks Moving Higher On Monday

The text discusses recent gains in the stock market, particularly for companies like Napco Security Technologies and SuperX AI Technology. US stocks were mixed, with the Dow Jones index gaining 150 points. Napco Security Technologies rose after better-than-expected results. Other big gainers include SuperX AI, Evolution Metals, and Cleveland-Cliffs.

Avi Kapoor

AstraZeneca, GameStop, Snap And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

U.S. stock futures higher, AstraZeneca dips on merger talks, Apple down 7.4%, other stocks moving lower in pre-market trading.

Avi Kapoor

Why Atkore Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket

Atkore Inc (ATKR) shares rise on strong Q3 results and acquisition by Prysmian for $95.00 per share. Other gainers include UPC, YYAI, RITR, FCUV, SGLY, FNGR, ALAR, FERG, and BMY while FMFC, PWCM, SITC, JDZG, and MGRX are among the losers.

Avi Kapoor

Dave and Buster's Reports Downbeat Q1 Earnings, Joins Alvotech And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

US stock futures up 0.1%, Dave and Buster's (PLAY) down 13.4% pre-market due to lower earnings; other stocks declining in pre-market trading

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-198.70M

Investing Cash Flow (TTM)

-146.18M

Financing Cash Flow (TTM)

335.93M

Free Cash Flow (TTM)

-333.82M

Capital Expenditure (TTM)

-135.12M

Net Change in Cash (TTM)

-8.95M

Analyst Trends and Forecast

Mar

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$3.18B

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

3.16

PB Ratio (TTM)

Earnings Yield % (TTM)

-11.81%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

20.97

Price / EBITDA (TTM)

10.25

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.54

Company Debt

Total Debt

$1.31B

LT Debt

$1.26B

LT Debt Issuance (TTM)

$239.69M

LT Debt Repayment (TTM)

-$49.47M

Total Cash

$142.75M

Debt to Equity

Issuance of Debt (TTM)

$190.22M

Repayment of Debt (TTM)

-$49.47M

Key Statistics

Open

$5.28

$5.29

Volume / Avg.

667.87K / 930.88K

Day Range

$5.26 - $5.39

52 Wk Range

2.94 - 9.25

Market Cap

$1.79B

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

3.93%

Days to Cover

4.36

About

Sector

Health Care

Industry

Biotechnology

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to trea...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

ALVO

ABBV

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

ALVO

ABBV

FAQ

How do I buy Alvotech (ALVO) stock?

You can purchase shares of Alvotech (NASDAQ:ALVO) through any online brokerage.

View our list of the best stock brokerages

Who are Alvotech (ALVO) competitors?

Other companies in Alvotech’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

What is the forecast, or price target, for Alvotech (ALVO) stock?

Alvotech has a consensus price target of $10.13.

What is the current price for Alvotech (ALVO)?

The stock price for Alvotech (NASDAQ: ALVO) is $5.29 last updated September 11, 2026 at 4:00 PM EDT.

Does Alvotech (ALVO) pay a dividend?

There are no upcoming dividends for Alvotech.

When is Alvotech (NASDAQ:ALVO) reporting earnings?

Alvotech does not have any upcoming earnings scheduled.

Is Alvotech (ALVO) going to split?

There is no upcoming split for Alvotech.

What sector and industry does Alvotech (ALVO) operate in?

Alvotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.